Wellington Management Company »

Vaneck Vectors Pharmaceutical etf shares owned by Wellington Management Company

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Wellington Management Company from 13F filings

Historical chart of Wellington Management Company investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by Wellington Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Wellington Management Company

Quarter filed Position value Share count Share price at filing
2025-12-31 $42M 408k 103.17

More positions owned by Wellington Management Company

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Amazon (AMZN)
Eli Lilly & Co. (LLY)
Merck & Co (MRK)
Mastercard Incorporated Cl A (MA)
Wells Fargo & Company (WFC)
Meta Platforms Cl A (META)
UnitedHealth (UNH)
Johnson & Johnson (JNJ)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)

View all positions for Wellington Management Company

Top funds holding Vaneck Vectors Pharmaceutical etf

Healthcare Of Ontario Pension Plan Trust Fund
Goldman Sachs Group
British Columbia Investment Management Corporation
Wells Fargo & Company
Wellington Management Company
Clal Insurance Enterprises Holdings
J.Safra Asset Management
Bnp Paribas Arbitrage, Snc
Avalon Trust
Miller Investment Management
Adamsbrown Wealth Consultants
Susquehanna International
UBS Group
LPL Financial
Prime Capital Investment Advisors

View all funds holding Vaneck Vectors Pharmaceutical etf